Back to Clinical Research

Double-Masked Uveitis Treatment

Status: Completed

ClinicalTrials.gov Identifier: NCT01358266

32-007: Phase 3 study of Intravitreal injections of DE-109 in patiens with active, non-infectious uveitis of the posterior segment of the eye.

Condition: Uveitis; Posterior, Disorder

Study Type: Interventional

Duration: 5 years and 7 months

Eligibility:

• Ages: 18 years and older
• Sexes: All
• Accepts Healthy Volunteers: No

For additional information on this study, please click here

Back to Clinical Research